Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 115   

Articles published

VRX 120.12 +3.13 (2.68%)
price chart
Valeant Pharmaceuticals International is Now Oversold (VRX)
In trading on Monday, shares of Valeant Pharmaceuticals International Valeant Pharmaceuticals International Inc (Toronto: VRX) entered into oversold territory, hitting an RSI reading of 27.8, after changing hands as low as $133.42 per share.
Related articles »  
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%
DUBLIN and LAVAL, Quebec, March 25, 2014 /CNW/ - Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug ...
Valeant Pharmaceuticals Intl Inc (VRX): How Proposed Tax Inversions Rule ...  iStockAnalyst (press release)
Valeant Pharmaceuticals Intl EVP Acquires $334861 in Stock (VRX)  Mideast Time
Related articles »  
BMO Capital Markets Lowers Valeant Pharmaceuticals Intl Price Target to ...
Valeant Pharmaceuticals International, Inc, formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Health Care Stocks Technical Coverage -- Research on Valeant Pharma Intl ...
Valeant Pharmaceuticals Intl. Inc.'s stock recorded a trading volume of 5.18 million shares, as compared with its three months average volume of 1.86 million shares.
Related articles »  
Valeant Pharmaceuticals Intl Given New $165.00 Price Target at BMO Capital ...
Valeant Pharmaceuticals International, Inc, formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Insider Selling: Norma Ann Provencio Sells 5000 Shares of Valeant ...
Valeant Pharmaceuticals International, Inc, formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Related articles »  
Valeant Pharmaceuticals Intl Inc (VRX) news: Riding Valeant's Momentum With ...
Shares of Valeant Pharmaceuticals (VRX) continue to march higher as earnings momentum begets stock price momentum. And though the detractors of Valeant's growth-by-acquisition strategy are growing louder, we've recently reiterated our Buy rating on ...
Valeant targets 'fat' in push for big leagues  bnn.ca
Related articles »  
Active Movers - Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Biogen Idec Inc ...
Las Vegas, NV - 05 April 2014 - (Tech Sonian) - Valeant Pharmaceuticals Intl Inc (NYSE:VRX) declared that the U.S. Food and Drug Administration (FDA) have approved the New Drug Application (NDA) for Metronidazole 1.3% Vaginal Gel, an antibiotic for ...
Unususal Volume Gainer � Valeant Pharmaceuticals Intl Inc (VRX), First ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) recently reported that the U.S. Food and Drug Administration has approved the New Drug Application for Metronidazole 1.3% Vaginal Gel, an antibiotic for the treatment of bacterial vaginosis.
Cantor Fitzgerald Initiates Coverage on Valeant Pharmaceuticals Intl (BVF)
Valeant Pharmaceuticals Intl Inc logo Cantor Fitzgerald began coverage on shares of Valeant Pharmaceuticals Intl (NYSE:BVF) in a research note issued to investors on Friday, AnalystRatingsNetwork reports.
Cantor Fitzgerald Initiates Coverage on Valeant Pharmaceuticals Intl (VRX)  Mideast Time
Valeant Pharmaceuticals Intl Given Consensus Rating of "Buy" by ...  Zolmax
Related articles »